Lennox (LII) Tops Q4 EPS by 15c, Beats on Revenue; Offers FY24 EPS Guidance
Tweet
Share
E-mailGet Alerts LII Hot Sheet
Price: $390.53 --0%
Revenue Growth %: +9.8%
Financial Fact:
Loss from discontinued operations: 0
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +9.8%
Financial Fact:
Loss from discontinued operations: 0
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Lennox (NYSE: LII) reported Q4 EPS of $3.63, $0.15 better than the analyst estimate of $3.48. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.14 billion.
GUIDANCE:
Lennox sees FY2024 EPS of $18.50-$20.00, versus the consensus of $19.80.
For earnings history and earnings-related data on Lennox (LII) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
- Erste Group Starts Marsh (MRSH) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
